TaiDoc Technology Corporation (4736.TW)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in TWD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | TWD m | 5,904 | 6,493 | 9,627 | 4,807 | 4,641 | 4,204 | 4,228 | - |
| Operating profit | TWD m | 956 | 780 | ||||||
| Net profit | TWD m | 1,521 | 1,975 | 3,383 | 1,017 | 1,159 | 1,442 | 2,565 | - |
| EPS reported | TWD | 15.02 | 25.63 | ||||||
| Operating cashflow per share | TWD | 8.82 | 10.92 | ||||||
| Capex per share | TWD | 2.60 | 2.82 | ||||||
| FCF per share | TWD | 6.22 | 8.11 | ||||||
| Free cash flow | TWD m | 602 | 780 | ||||||
| Net debt | TWD m | -4,074 | -5,320 | ||||||
| Book value equity | TWD m | 9,786 | 11,007 | ||||||
| Book value per share | TWD | 101.1 | 114.4 | ||||||
| Number of shares | m | 96.77 | 96.21 | ||||||
| DPS (TTM paid) | TWD | 9.08 | 5.07 |
Financial summary
Financials in TWD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | 7.70 | ||||||
| P/B LTM | x | 1.09 | 0.97 | ||||||
| P/S LTM | x | 2.54 | 2.52 | ||||||
| P/FCF LTM | x | 17.73 | 13.68 | ||||||
| EV/EBITDA LTM | x | 8.92 | 10.50 | ||||||
| EV/Sales LTM | x | 2.32 | 2.50 | ||||||
| Earnings Yield LTM | % | +13.51% | +12.99% | ||||||
| FCF Yield | % | +5.64% | +7.31% | ||||||
| Quality | |||||||||
| ROE | % | +14.73% | +25.77% | ||||||
| ROIC | % | +7.22% | +5.77% | ||||||
| Operating margin | % | +22.74% | +18.45% | ||||||
| Gross margin | % | +45.96% | +42.53% | ||||||
| FCF/Sales | % | +14.32% | +18.45% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +24.13% | +111.82% | ||||||
| Sales Growth YoY | % | -9.41% | -8.89% | ||||||
| Net Income Growth YoY | % | +24.43% | +121.32% | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | +18.75% | -3.12% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +8.67% | +3.99% | ||||||
| Dividend Growth | % | 0.00% | -44.15% | ||||||
| Payout Ratio | % | +63.69% | +52.76% | ||||||
| FCF/Debt | x | 0.52 | 0.83 | ||||||
| Net Debt/EBITDA | x | -0.83 | -1.66 | ||||||
| EBIT/Net interest | x | 46.03 | 619.13 | ||||||
| Net debt/market cap | % | +10.79% | +7.76% | ||||||
| Net debt/Equity | x | -0.42 | -0.48 | ||||||
| Gross debt/equity | x | 0.12 | 0.09 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
TaiDoc Technology Corporation, established in 1998 and based in New Taipei City, Taiwan, is a leading global producer and distributor of a wide array of medical devices. The company's comprehensive product catalog features advanced in vitro diagnostics, including multi-parameter monitoring systems, convenient point-of-care testing (POCT) devices, and precision lancet and lancing tools. For animal health, TaiDoc offers specialized veterinary diagnostics such as blood glucose, calcium, and ketone meters. Beyond diagnostics, their general medical equipment range encompasses vital devices like nebulizers, thermometers, blood pressure monitors, vital sign monitors, and pulse oximeters. In the connected health sector, they develop remote telehealth monitoring devices alongside user-friendly smartphone applications. The company also contributes to infectious disease screening, providing rapid antigen test kits for conditions like COVID-19. In addition to its product offerings, TaiDoc delivers value-added services, assisting clients with regulatory professional guidance, clinical consultation, engineering support, and sophisticated manufacturing system solutions. Furthermore, they offer a suite of proprietary software applications designed to enhance device functionality and user experience, such as MyLink, ProCheck, Healthy Check, Healthy Check PRO, PCLink, and a USB adapter driver.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
TaiDoc Technology Corporation (4736.TW)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
TaiDoc Technology Corporation, established in 1998 and based in New Taipei City, Taiwan, is a leading global producer and distributor of a wide array of medical devices. The company's comprehensive product catalog features advanced in vitro diagnostics, including multi-parameter monitoring systems, convenient point-of-care testing (POCT) devices, and precision lancet and lancing tools. For animal health, TaiDoc offers specialized veterinary diagnostics such as blood glucose, calcium, and ketone meters. Beyond diagnostics, their general medical equipment range encompasses vital devices like nebulizers, thermometers, blood pressure monitors, vital sign monitors, and pulse oximeters. In the connected health sector, they develop remote telehealth monitoring devices alongside user-friendly smartphone applications. The company also contributes to infectious disease screening, providing rapid antigen test kits for conditions like COVID-19. In addition to its product offerings, TaiDoc delivers value-added services, assisting clients with regulatory professional guidance, clinical consultation, engineering support, and sophisticated manufacturing system solutions. Furthermore, they offer a suite of proprietary software applications designed to enhance device functionality and user experience, such as MyLink, ProCheck, Healthy Check, Healthy Check PRO, PCLink, and a USB adapter driver.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free